Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MSP Vaccines
Winnipeg, Manitoba, Canadamspvaccines.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
MSP Vaccines is a biotechnology company focused on the development of innovative veterinary vaccines using a proprietary plant-based production platform. The company specializes in creating recombinant protein vaccines for the livestock industry, with a primary focus on swine health. By utilizing plant-based expression systems, MSP Vaccines aims to provide cost-effective, scalable, and safe alternatives to traditional vaccine manufacturing methods. Their lead programs target significant porcine pathogens, including Porcine Circovirus Type 2 (PCV2) and Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineBiologicRecombinant protein
- Industry
- Veterinary
Beyond the preview
Go deeper on MSP Vaccines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MSP Vaccines.